TAM Macro‐2 loses the expression of CD86, a potent co‐stimulatory signal necessary for T cell activation and survival, and is almost exclusively found in patients with cancer; therefore, we termed this subset TAM Macro‐2. The gene discussed is CD86; the disease is cancer.